The post Insufficient Sleep Is A Growing Crisis appeared on BitcoinEthereumNews.com. Melatonin is one of the most widely used sleep supplements. getty A study publishedThe post Insufficient Sleep Is A Growing Crisis appeared on BitcoinEthereumNews.com. Melatonin is one of the most widely used sleep supplements. getty A study published

Insufficient Sleep Is A Growing Crisis

Melatonin is one of the most widely used sleep supplements.

getty

A study published in 2018 in Healthcare found that in a study of nearly 20,000 individuals, it was reported that almost 27.3% individuals reported they had some type of sleep disorder. Another more recent study indicates that nearly 33% of adults reported insufficient sleep and short-sleep cycles. With growing economies, increasing labor needs and rising wage challenges, insufficient sleep has grown to become a worldwide phenomenon. In fact, many experts attribute these growing trends to increasing stress levels as a part of a viscious cycle: “It is believed that the relationship between stress and sleep is bidirectional—that is, stress can disrupt sleep and sleep loss can increase subsequent stress level.”

Research has also overwhelmingly indicated that lack of sleep can lead to numerous health detriments, including chronic disease, mental health deterioration and even behavioral disorders.

People are increasingly realizing this problem; with increasingly busy lives, more screen time and poorer sleep hygiene, individuals are increasingly relying on supplements, such as melatonin, to help them sleep more.

A new study published by the American Heart Association late last year found an association between long-term melatonin use and heart failure. Specifically, the study reviewed records of over 130,000 adults who used melatonin for needs related to insomnia or sleep disturbances and found a higher likelihood of being diagnosed with heart failure leading to hospitalization. Though not necessarily a finding of causality, the study calls for more research and awareness into the common and routine use of melatonin by millions of individuals daily.

Melatonin is a hormone that is naturally produced by the body to help regulate the sleep-wake cycle; typically, its levels increase during darkness and decrease during daylight, mirroring natural human circadian rhythms. The hormone binds to MT1 and MT2 receptors, triggering a variety of downstream physiological processes to induce fatigue, sleepiness and a generalized “tone of rest.”

For years, synthetic preparations of melatonin have been available for purchase by consumers over-the-counter and commonly marketed as a sleeping aid or solution for circiadian disturbances. However, as the substance is considered a supplement and not a medicine, formulations by manufacturers often bypass strict regulatory controls. In fact, in Europe and countries in Asia, melatonin cannot be acquired without a doctor’s prescription due to the significant impacts it can have with long-term use.

Another study published last year in the World Journal of Pediatrics found that the long-term effects of melatonin on children are simply unknown, despite skyrocketing use in pediatric populations globally. The study also cites that there is no clear efficacy or safety data which can strongly point towards downstream physiologic and pathologic impacts. Despite a lack of clear data on the safety and prognostic findings, melatonin use in young children is common, underscoring the need for more research in age-specific cohorts. Per a recent literature review, it was found that “the use of melatonin as a sleep aid for children younger than age 6 has increased around the world over the last 20 years, and especially over the last decade. In countries where melatonin requires a prescription, these prescriptions have increased by as much as 500% in some areas. Moreover, the studies showed increases in extended use of melatonin, with young children getting refills two and three years after the initial prescription.”

Fortunately, there has been more awareness and education over the past decade regarding non-medication related interventions to improve sleep for both pediatric and adult populations. Wellness clinics are increasingly emerging across the globe to help institute better sleep routines and methods for patients. New wearbles and activity trackers are including sleep monitoring into their hardware. Even new phone applications have been developed solely for the endeavor of helping users sleep. There is also more research and conversation around this topic. Experts broadly encourage improving sleep hygiene with easy but key changes including maintaining a consistent schedule, a darker environment during sleeping hours, less screen time prior to sleep, and consistent day-time habits that promote more regular circadian rhythms, including caffeine restriction and exercise. Through these methods, the hope is that societal outcomes for sleep efficacy can improve.

Source: https://www.forbes.com/sites/saibala/2026/01/21/insufficient-sleep-is-a-growing-crisis/

Market Opportunity
Humans.ai Logo
Humans.ai Price(HEART)
$0.001358
$0.001358$0.001358
-1.52%
USD
Humans.ai (HEART) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week

Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week

TLDR Bitcoin ETFs recorded their strongest weekly inflows since July, reaching 20,685 BTC. U.S. Bitcoin ETFs contributed nearly 97% of the total inflows last week. The surge in Bitcoin ETF inflows pushed holdings to a new high of 1.32 million BTC. Fidelity’s FBTC product accounted for 36% of the total inflows, marking an 18-month high. [...] The post Bitcoin ETFs Surge with 20,685 BTC Inflows, Marking Strongest Week appeared first on CoinCentral.
Share
Coincentral2025/09/18 02:30
XAG/USD retreats toward $113.00 on profit-taking pressure

XAG/USD retreats toward $113.00 on profit-taking pressure

The post XAG/USD retreats toward $113.00 on profit-taking pressure appeared on BitcoinEthereumNews.com. Silver price (XAG/USD) halts its seven-day winning streak
Share
BitcoinEthereumNews2026/01/30 10:21
BTC Leverage Builds Near $120K, Big Test Ahead

BTC Leverage Builds Near $120K, Big Test Ahead

The post BTC Leverage Builds Near $120K, Big Test Ahead appeared on BitcoinEthereumNews.com. Key Insights: Heavy leverage builds at $118K–$120K, turning the zone into Bitcoin’s next critical resistance test. Rejection from point of interest with delta divergences suggests cooling momentum after the recent FOMC-driven spike. Support levels at $114K–$115K may attract buyers if BTC fails to break above $120K. BTC Leverage Builds Near $120K, Big Test Ahead Bitcoin was trading around $117,099, with daily volume close to $59.1 billion. The price has seen a marginal 0.01% gain over the past 24 hours and a 2% rise in the past week. Data shared by Killa points to heavy leverage building between $118,000 and $120,000. Heatmap charts back this up, showing dense liquidity bands in that zone. Such clusters of orders often act as magnets for price action, as markets tend to move where liquidity is stacked. Price Action Around the POI Analysis from JoelXBT highlights how Bitcoin tapped into a key point of interest (POI) during the recent FOMC-driven spike. This move coincided with what was called the “zone of max delta pain”, a level where aggressive volume left imbalances in order flow. Source: JoelXBT /X Following the test of this area, BTC faced rejection and began to pull back. Delta indicators revealed extended divergences, with price rising while buyer strength weakened. That mismatch suggests demand failed to keep up with the pace of the rally, leaving room for short-term cooling. Resistance and Support Levels The $118K–$120K range now stands as a major resistance band. A clean move through $120K could force leveraged shorts to cover, potentially driving further upside. On the downside, smaller liquidity clusters are visible near $114K–$115K. If rejection holds at the top, these levels are likely to act as the first supports where buyers may attempt to step in. Market Outlook Bitcoin’s next decisive move will likely form around the…
Share
BitcoinEthereumNews2025/09/18 16:40